INCB057643
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for INCB057643, covering 2022-04-28 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms [Phase 1]